Clinical cardiovascular impact of valvular heart disease subtypes in chronic hemodialysis patients
Year: 2026
Type: article
Study design: Observational Study
Abstract: Valvular heart disease (VHD) is highly prevalent in patients with end-stage kidney disease (ESKD) undergoing hemodialysis (HD), and is linked to adverse cardiovascular outcomes. However, data remain limited regarding its prognosis impact across different types of VHD in the population. We conducted a retrospective cohort study of 238 chronic HD patients with echocardiographic assessments at a single medical center. VHD was identified and classified by lesion types and number of affected valves (isolated vs. multivalvular). Clinical outcomes included all-cause mortality, major adverse cardiovascular events (MACE), and cardiovascular mortality. Cox proportional hazards models and Kaplan-Meier analyses were used for analysis. VHD was present in 87.4% of the cohort, with mitral regurgitation (MR) being the most common (91.3%), followed by aortic regurgitation (48.6%), aortic stenosis (13.0%), and mitral stenosis (1.4%). VHD patients were older and had higher coronary artery disease prevalence. Although VHD presence was not significantly associated with adverse outcomes in multivariable models, Kaplan-Meier analysis showed higher event trends (MACE: 38% vs. 20%; CV mortality: 18.3% vs. 6.7%). Subgroup analysis revealed that aortic stenosis (AS) was significantly associated with increased MACE risk (adjusted HR: 1.919; 95% CI: 1.065–3.548), and exploratory analyses suggested MR might be associated with all-cause mortality (adjusted HR: 2.538; 95% CI: 1.000–6.446). While overall VHD presence was not independently predictive of adverse outcomes, exploratory analyses identified potential associations between specific valvular lesions, such as AS and MR, and adverse clinical outcomes, emphasizing the need for further VHD subtype evaluation and risk stratification in chronic HD population.
Source: BMC Nephrology
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7234056229
